Abivax S.a. share price logo

Abivax S.a. Share Price

NASDAQ: ABVX

Mid Cap

$118.40

+3.43

(+2.98%)

as on

Abivax S.a. Stock Performance

as on April 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $112.79
    $119.79
    downward going graph

    4.74%

    Downside

    1.17%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.77
    $148.83
    downward going graph

    95.97%

    Downside

    25.70%

    Upside

    downward going graph

Abivax S.a. share price movements today

Previous Close
$114.97
Open
$112.82
Volume
1.0M
Day's Low - High
$112.79 - $119.79
52 Week Low - High
$4.77 - $148.83

Abivax S.a. Historical Returns

1 Month Return
+ 1.37 %
3 Month Return
-11.51 %
1 Year Return
+ 2125 %
3 Year Return
0 %
5 Year Return
0 %

Abivax S.a. Stock Fundamentals & Key Indicators

Check Abivax S.a. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.4B

EPS (TTM)

-3.6312

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-245.0M

Revenue (TTM)

4.6M

Profit Margin

0.00%

Return On Equity TTM

-135.58%

Abivax S.a. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abivax S.a. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Abivax S.a. image
Abivax S.a.
BUY$9.4BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B124.84%136.858.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA125.835.37%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B105.93%28.6632.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B60.41%18.3831.41%

Stock Returns calculator for Abivax S.a. Stock including INR - Dollar returns

The Abivax S.a. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Abivax S.a. investment value today

Current value as on today

₹24,01,484

Returns

₹23,01,484

(+2.3K%)

Returns from Abivax S.a. Stock

₹21,25,564 (+2.13K%)

Dollar Impact

₹1,75,920 (+175.92%)

Analyst Recommendation on Abivax S.a. Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Abivax S.a.. Average target price of $155.2

Abivax S.a. Share Price Target

Get share price movements and forecasts by analysts on Abivax S.a..

What analysts predicted

23.71%UPSIDE

Target Price

$155.2

Current Price

$118.4

Analyzed by

14 Analysts

Target

$155.20

Abivax S.a. target price $155.2, a slight upside of 23.71% compared to current price of $118.4. According to 14 analysts rating.

Abivax S.a. Stock’s Investor Sentiment and Interest

Search interest for Abivax S.a. Stock has increased by 42% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:42% versus previous 30 day period

Abivax S.a. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
2
-
3
-
7
-
2
-
-2
Gross Profit
2
2
-
3
-
7
-
2
-
-3
Operating Income
-39
-92
-44
-39
-50
-132
-47
-93
-80
-147
EBITDA
-39
-92
-
-39
-
-131
-
-93
-
-146
Interest Expense
14
5
2
0
4
1
4
7
4
20
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-54
-98
-42
-40
-55
-94
-52
-100
-153
-219
Income Tax Expense
-2
-2
-
-
-
-
-
-
-
2
Net Income
-56
-104
-46
-43
-61
-98
-56
-100
-153
-222
Net Profit Margin
-2311.08%
-4118.10%
0.00%
-1203.04%
0.00%
-1278.61%
0.00%
-4996.73%
0.00%
11009.07%

Abivax S.a. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
4
5
11
-
Gross Profit
-15
0
0
-31
-41
0
4
4
11
-1
Operating Income
-18
-14
-19
-33
-38
-41
-64
-127
-172
-240
EBITDA
-18
-13
-19
-33
-37
-38
-53
-133
-171
-239
Interest Expense
0
0
0
1
2
3
6
13
4
27
Depreciation
-
-
-
0
0
0
0
0
1
1
Income Before Tax
-17
-14
-19
-34
-40
-42
-74
-152
-176
-320
Income Tax Expense
-3
-2
-3
-4
-2
-4
-4
-4
-
2
Net Income
-15
-13
-17
-34
-45
-47
-64
-161
-184
-322
Net Profit Margin
-11266.14%
-112230.00%
-87905.56%
-1531700.00%
-59604.76%
-114735.14%
-1325.33%
-3197.14%
-1633.08%
0.00%

Abivax S.a. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-95
-42
-40
-55
-94
-52
-100
-153
-222
Operating Cash Flow
-71
-34
-42
-35
-68
-33
-66
-71
-89
Investing Cash Flow
-8
-
13
-
1
-
1
-
-14
Financing Cash Flow
222
21
40
-6
-12
-7
-8
603
540
Change in Cash
137
-10
-19
-41
-36
-40
60
528
455

Abivax S.a. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-19
-33
-38
-42
-60
-147
-176
-322
Operating Cash Flow
-8
-14
-27
-29
-45
-53
-100
-154
-155
Investing Cash Flow
0
0
0
0
-1
-12
-10
15
-13
Financing Cash Flow
2
10
24
49
78
32
340
28
531
Change in Cash
-5
-4
-3
19
31
-33
224
-107
389

Abivax S.a. News & Key Events

  • img

    Today's Timeline - 16 March

    Mon, 04:32 PM

    -

    Jefferies initiates Abivax with a buy rating, citing strong potential for obefazimod in inflammatory bowel disease market.

Insights on Abivax S.a.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABVX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ABVX stock has moved up by 2125.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 7.39M → -2.01M (in $), with an average decrease of 136.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -52.37M → -222.05M (in $), with an average decrease of 63.1% per quarter

About Abivax S.a.

Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
OrganisationAbivax S.a.
Headquarters7-11 boulevard Haussmann, Paris, France, 75009
CEOMr. Didier Blondel
E-voting on sharesClick here to vote

Key Management of Abivax S.a.

Name

Title

Ms. Ida Hatoum

Chief People & Compliance Officer

Mr. Didier Blondel

EVP, CFO & Board Secretary

Mr. Patrick Malloy

Senior Vice President of Investor Relations

Mr. Jerome Denis Ph.D.

Executive Vice President of Process Development & Manufacturing

Hema Keshava

Senior Vice President of Finance

Chris Rabbat Ph.D.

VP & Global Head of Medical Affairs

Kevin Shan Ph.D.

VP & Global Head of Biometrics

Mary Mantock

Senior VP & Global Head of Regulatory Affairs

Dr. Douglas Jacobstein M.D.

Senior VP & Global Head of Clinical Development

Ms. Nadege Briancon-Eris Ph.D.

Senior VP & Global Head of Program Management

FAQs

What is Abivax S.a. share price today?

Abivax S.a. share price today is $118.4 as on at the close of the market. Abivax S.a. share today touched a day high of $119.79 and a low of $112.79.

What is the 52 week high and 52 week low for Abivax S.a. share?

Abivax S.a. share touched a 52 week high of $148.83 on and a 52 week low of $4.77 on . Abivax S.a. stock price today i.e. is closed at $118.4,which is 20.45% down from its 52 week high and 2382.18% up from its 52 week low.

What is Abivax S.a.'s market capitalisation today?

Abivax S.a. market capitalisation is $0.01T as on .

How to invest in Abivax S.a. Stock (ABVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abivax S.a. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abivax S.a. Shares that will get you 0.0127 shares as per Abivax S.a. share price of $118.4 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Abivax S.a. Stock (ABVX) from India?

Indian investors can start investing in Abivax S.a. (ABVX) shares with as little as ₹92.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Abivax S.a. stock (as per the Rupee-Dollar exchange rate as on ). Based on Abivax S.a. share’s latest price of $118.4 as on April 3, 2026 at 1:29 am IST, you will get 0.0845 shares of Abivax S.a.. Learn more about fractional shares .